General
Preferred name
ZAFIRLUKAST
Synonyms
CPD000466316 ()
ICI 204219 ()
Accolate ()
Vanticon ()
Zafirlukast (ICI-204219) ()
ICI-204219 ()
Ici-204,219 ()
ICI 204,219 ()
P&D ID
PD002945
CAS
107753-78-6
Tags
probe
natural product
drug
available
Approved by
FDA
First approval
1996
Drug Status
investigational
approved
Drug indication
Anti-Asthmatic (leukotriene antagonist)
Asthma
Max Phase
Phase 4
Probe info
Probe selectivity
protein-selective
Probe type
P&D approved
calculated probe
Probe targets
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Zafirlukast is an oral leukotriene receptor antagonist (LTRA), with selectivity for cysteinyl leukotriene receptor 1 (CysLT1 receptor). (GtoPdb)
Cell lines
1
Organisms
3
Compound Sets
36
Bioprocess diversity set
Cayman Chemical Bioactives
CeMM library of unique drugs (CLOUD)
ChEMBL Approved Drugs
ChEMBL Drugs
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
DrugMatrix
Enamine BioReference Compounds
EUbOPEN Chemogenomics Library
Guide to Pharmacology
High-quality chemical probes
Ki Database
LSP-MoA library (Laboratory of Systems Pharmacology)
LSP-OptimalKinase library (Laboratory of Systems Pharmacology)
Mcule NIBR MoA Box Subset
MedChem Express Bioactive Compound Library
NCATS Inxight Approved Drugs
NIH Clinical Collections (NCC)
Novartis Chemogenetic Library (NIBR MoA Box)
NPC Screening Collection
Prestwick Chemical Library
Probe Miner (suitable probes)
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
ZINC Tool Compounds
External IDs
37
Properties
(calculated by RDKit )
Molecular Weight
575.21
Hydrogen Bond Acceptors
7
Hydrogen Bond Donors
2
Rotatable Bonds
8
Ring Count
5
Aromatic Ring Count
4
cLogP
5.7
TPSA
115.73
Fraction CSP3
0.29
Chiral centers
0.0
Largest ring
6.0
QED
0.28
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Biological process
Cytokinesis
MOA
Leukotriene Receptor Antagonist
Leukotriene CysLT1 (LTD4) Antagonists
Target
Cysteinyl leukotriene receptor 1
Leukotriene Receptor
CYSLTR1, CYSLTR2
LTR
Member status
member
Indication
asthma
Therapeutic Class
Antiasthmatic Agents
Pathway
GPCR/G protein
Source data